Artia Global Partners »

SPDR S&P Biotech shares owned by Artia Global Partners

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Artia Global Partners from 13F filings

Historical chart of Artia Global Partners investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Artia Global Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Artia Global Partners

Quarter filed Position value Share count Share price at filing
2025-06-30 $8.3M 100k 82.93
2024-12-31 $9.0M 100k 90.06

More positions owned by Artia Global Partners

Insmed Com Par $.01 (INSM)
Argenx Se Sponsored Adr (ARGX)
Soleno Therapeutics (SLNO)
Verona Pharma Sponsored Ads (VRNA)
Uniqure Nv SHS (QURE)
Merus N V (MRUS)
Proshares Tr Ii Ultra Gold (UGL)
Eli Lilly & Co. (LLY)
Vertex Pharmaceuticals Incorporated (VRTX)
Abivax Sa Sponsored Ads (ABVX)
Trevi Therapeutics (TRVI)
Boston Scientific Corporation (BSX)
Alnylam Pharmaceuticals (ALNY)
Quest Diagnostics Incorporated (DGX)
Astrazeneca Sponsored Adr (AZN)

View all positions for Artia Global Partners

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Jpmorgan Chase & Co
Morgan Stanley
Susquehanna International
Citadel Advisors
Jane Street
Bnp Paribas Arbitrage, Snc
Millennium Management
Peak6
UBS Group
Wells Fargo & Company
Barclays
Balyasny Asset Management
Canada Pension Plan Investment Board

View all funds holding SPDR S&P Biotech